Astronomers warn that megaconstellations of satellites will obstruct our view of the cosmos, writes Rebecca Cadenhead, The Wall Street Journal.
To accomplish anything durable in the next two years, the president will have to accept compromise and limits to his authority, write Annie Linskey, Josh Dawsey, Meridith McGraw and Eliza Collins, The Wall Street Journal.
The marketing tech company Xtremepush expects its revenue to hit €40m as it grows by 30% this year. Its CEO explains how AI is helping it reach its global ambition.
Four years after his rugby club collapsed, Richardson is deep in court battles with AIB over debts and his former financial advisors over alleged deceit and misrepresentation.
“Everyone is going to have to take a certain commercial view for us to get it over the line at this stage,” said Justice Eileen Roberts.
David O'Shea faced questions from liquidators about an €11m Blackrock bond, including a €3m loan that gave another lender priority over investors and secured rental income allegedly spent elsewhere.
No drug designed by artificial intelligence has won FDA clearance, and pharma leaders say biology is the obstacle writes Xavier Martinez, The Wall Street Journal.
Republican midterm losses leave the president weakened during his final two years in the White House, writes Aaron Zitner, The Wall Street Journal.
Nomad Capitalist says it has relocated over 3,000 wealthy individuals. Founder Andrew Henderson discusses his “avant-garde” company, his stint in Ireland, and the ethics of helping rich people pay less.
Bimeda, controlled by the Tierney family, launched a new worm treatment for animals in the US that Elanco claims bears similarities to its product.
© 2026 Currency Media Limited